Home Cart 0 Sign in  
X

[ CAS No. 18179-39-0 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 18179-39-0
Chemical Structure| 18179-39-0
Chemical Structure| 18179-39-0
Structure of 18179-39-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 18179-39-0 ]

Related Doc. of [ 18179-39-0 ]

Alternatived Products of [ 18179-39-0 ]

Product Details of [ 18179-39-0 ]

CAS No. :18179-39-0 MDL No. :MFCD06797864
Formula : C8H7IO3 Boiling Point : -
Linear Structure Formula :- InChI Key :WUFUURSWOJROKY-UHFFFAOYSA-N
M.W :278.04 Pubchem ID :11380407
Synonyms :

Calculated chemistry of [ 18179-39-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.46
TPSA : 46.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.06
Log Po/w (XLOGP3) : 3.2
Log Po/w (WLOGP) : 1.78
Log Po/w (MLOGP) : 2.21
Log Po/w (SILICOS-IT) : 2.18
Consensus Log Po/w : 2.29

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.82
Solubility : 0.0423 mg/ml ; 0.000152 mol/l
Class : Soluble
Log S (Ali) : -3.85
Solubility : 0.0394 mg/ml ; 0.000142 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.85
Solubility : 0.395 mg/ml ; 0.00142 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.89

Safety of [ 18179-39-0 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 18179-39-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 18179-39-0 ]
  • Downstream synthetic route of [ 18179-39-0 ]

[ 18179-39-0 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 16870-28-3 ]
  • [ 74-88-4 ]
  • [ 18179-39-0 ]
YieldReaction ConditionsOperation in experiment
76.5%
Stage #1: With sodium hydrogencarbonate In N,N-dimethyl-formamide for 0.0833333 h;
Stage #2: at 40℃; for 5 h;
4-Iodosalicylic acid 60 (7.3 g, 27.65 mmol) was dissolved in 41 ml DMF and NaHCO3 (2.78 g, 33.18 mmol) were added (evolution of CO2) and the mixture stirred for 5 min. MeI (2.66 ml, 5.85 g, 41.47 mmol, 1.5 eq) was added and the reaction mixture was heated to 40° C. for 5 h while stirring (monitored by TLC). Upon reaction completion, the mixture was diluted with 170 ml H2O and 170 ml EA. The organic layer was subsequently washed with 170 ml of 5percent NaHCO3, 170 ml 5percent NaCl and was dried over Na2SO4. The solvent was evaporated to give ˜9 g of crude oily product (black color), which was purified by column chromatography: SiO2 (100 g), Hexane, Hexane:EA 100:2. 5.86 g, Yield: 76.5percent.
Reference: [1] Patent: US2016/2269, 2016, A1, . Location in patent: Paragraph 0253; 0254
  • 2
  • [ 67-56-1 ]
  • [ 16870-28-3 ]
  • [ 18179-39-0 ]
YieldReaction ConditionsOperation in experiment
50% for 10 h; Reflux Synthesis of Compound 3 10.0 g (37.8 mmol) of Compound 2 was taken in 200.0 ml dry methanol. To this 11.5 ml (151.0 mmol) of SOCl2 was added drop wise. Then the reaction mixture was refluxed for 10 h. After completion of reaction, the reaction mixture was cooled to room temperature and methanol was evaporated to dryness under vacuum to obtain 12.0 g crude product which was further purified by washing with minimum amount of methanol to obtain 5.2 g of Compound 3. Yield: 50.0percent Analysis: 1H NMR (300 MHz, CDCl3): δ 10.8 (s, 1H); 7.49 (d, 1H); 7.40 (d, 1H); 7.24 (dd, 1H); 3.9 (s, 3H). MS (m/z): 277 (M+−H)
50% for 10 h; Reflux Synthesis of Compound 3 10.0 g (37.8 mmol) of Compound 2 was taken in 200.0 ml dry methanol. To this 11.5 ml (151.0 mmol) of SOCl2 was added drop wise. Then the reaction mixture was refluxed for 10 h. After completion of reaction, the reaction mixture was cooled to room temperature and methanol was evaporated to dryness under vacuum to obtain 12.0 g crude product which was further purified by washing with minimum amount of methanol to obtain 5.2 g of Compound 3. Yield: 50.0percent Analysis: 1H NMR (300 MHz, CDCl3): δ 10.8 (s, 1H); 7.49 (d, 1H); 7.40 (d, 1H); 7.24 (dd, 1H); 3.9 (s, 3H). MS (m/z): 277 (M+−H)
Reference: [1] Patent: US2014/81044, 2014, A1, . Location in patent: Paragraph 0150-0153
[2] Patent: WO2014/45135, 2014, A1, . Location in patent: Page/Page column 16-17
[3] Patent: WO2007/77961, 2007, A2, . Location in patent: Page/Page column 320
[4] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 18, p. 6567 - 6582
  • 3
  • [ 16870-28-3 ]
  • [ 18107-18-1 ]
  • [ 18179-39-0 ]
Reference: [1] Patent: US2008/194668, 2008, A1, . Location in patent: Page/Page column 7
  • 4
  • [ 4136-97-4 ]
  • [ 18179-39-0 ]
Reference: [1] Bulletin of the Korean Chemical Society, 2010, vol. 31, # 12, p. 3860 - 3863
  • 5
  • [ 65-49-6 ]
  • [ 18107-18-1 ]
  • [ 18179-39-0 ]
Reference: [1] Patent: WO2007/37187, 2007, A1, . Location in patent: Page/Page column 132
  • 6
  • [ 65-49-6 ]
  • [ 18179-39-0 ]
Reference: [1] Patent: US2014/81044, 2014, A1,
[2] Patent: WO2014/45135, 2014, A1,
[3] Patent: US2016/2269, 2016, A1,
  • 7
  • [ 67-56-1 ]
  • [ 813-78-5 ]
  • [ 18179-39-0 ]
Reference: [1] Journal of the American Chemical Society, 2009, vol. 131, p. 368 - 377
  • 8
  • [ 124-41-4 ]
  • [ 512-56-1 ]
  • [ 18179-39-0 ]
Reference: [1] Journal of the American Chemical Society, 2009, vol. 131, # 38, p. 13738 - 13748
  • 9
  • [ 18179-39-0 ]
  • [ 38170-02-4 ]
Reference: [1] Journal of Pharmacy and Pharmacology, 2016, vol. 68, # 2, p. 233 - 244
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 18179-39-0 ]

Aryls

Chemical Structure| 15125-84-5

[ 15125-84-5 ]

Ethyl 2-hydroxy-5-iodobenzoate

Similarity: 0.95

Chemical Structure| 2786-00-7

[ 2786-00-7 ]

5-Iodo-2-methoxybenzoic acid

Similarity: 0.93

Chemical Structure| 66195-39-9

[ 66195-39-9 ]

2-Iodo-6-methoxybenzoic acid

Similarity: 0.90

Chemical Structure| 5471-81-8

[ 5471-81-8 ]

Methyl 4-iodo-3-methylbenzoate

Similarity: 0.88

Chemical Structure| 157942-12-6

[ 157942-12-6 ]

Methyl 3-hydroxy-4-iodobenzoate

Similarity: 0.87

Esters

Chemical Structure| 15125-84-5

[ 15125-84-5 ]

Ethyl 2-hydroxy-5-iodobenzoate

Similarity: 0.95

Chemical Structure| 5471-81-8

[ 5471-81-8 ]

Methyl 4-iodo-3-methylbenzoate

Similarity: 0.88

Chemical Structure| 15126-06-4

[ 15126-06-4 ]

Methyl 4-hydroxy-3-iodobenzoate

Similarity: 0.87

Chemical Structure| 157942-12-6

[ 157942-12-6 ]

Methyl 3-hydroxy-4-iodobenzoate

Similarity: 0.87

Chemical Structure| 619-44-3

[ 619-44-3 ]

Methyl 4-iodobenzoate

Similarity: 0.86